IBEX is delighted to announce that Dr Paul Scott has been appointed as CEO. The appointment is part of a planned transition with previous CEO Dr Neil Loxley moving to the IBEX Chairman position.
Neil commented: “Paul and I have worked together for the past 10 years to build a fantastic company and a world-beating medical software product that is due to be released to market at the end of this year.
"Following our recent funding round, this is the ideal time for me to pass the CEO reins to Paul and to support him to drive future growth. I am looking forward to working closely with Paul and as we realise our vision to transform lives through early detection of osteoporosis from routine X-rays.”
Find out more about IBEX here.
